Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy

Katie Wakeham(Royal Sussex County Hospital), Duncan C. Gilbert(Royal Sussex County Hospital), Laura Murphy(Brigham and Women's Hospital), K. Sleigh(Royal Sussex County Hospital), M. Hawkins(University College Hospital), David Sebag‐Montefiore(University of Leeds), C. Morgan(Royal Sussex County Hospital), Gareth J. Thomas(University of Southampton), Sarah Brown(University of Leeds), Louise Murray(Leeds Teaching Hospitals NHS Trust), Max Whibley(Royal Sussex County Hospital), R. Muirhead(Churchill Hospital), Sue Bell(University of Leeds)
Clinical Oncology
May 21, 2021
10.1016/j.clon.2021.04.015
Cited by 17

Related Papers

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
|The Lancet|2009|1.1k
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640
Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
|Journal of Clinical Oncology|2008|597
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
|The Lancet|2010|571